| Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study LC Abu Esba, RA Alqahtani, A Thomas, N Shamas, L Alswaidan, ... Infectious diseases and therapy 10, 253-268, 2021 | 105 | 2021 |
| Reported Adverse Effects following COVID-19 Vaccination at a Tertiary Care Hospital, Focus on Cerebral Venous Sinus Thrombosis (CVST) LA Esba, M Al Jeraisy Expert Review of Vaccines, 2021 | 34 | 2021 |
| Adoption of a personal health record in the digital age: Cross-sectional study CC Yousef, A Thomas, AO Alenazi, S Elgadi, LC Abu Esba, A AlAzmi, ... Journal of medical Internet research 22 (10), e22913, 2020 | 26 | 2020 |
| Health care providers’ acceptance of a personal health record: cross-sectional study CC Yousef, TM Salgado, A Farooq, K Burnett, LE McClelland, ... Journal of medical Internet research 23 (10), e31582, 2021 | 17 | 2021 |
| Predicting patients’ intention to use a personal health record using an adapted unified theory of acceptance and use of technology model: secondary data analysis CC Yousef, TM Salgado, A Farooq, K Burnett, LE McClelland, A Thomas, ... JMIR medical informatics 9 (8), e30214, 2021 | 14 | 2021 |
| Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented MS Laila Carolina Abu Esba BSc, MSc, PharmD Ghada Al Mardawi BSc, SSC‐PhP ... The Journal of Clinical Pharmacy and Therapeutics, 2020 | 14* | 2020 |
| Acute kidney injury in pediatric treated with vancomycin and piperacillin-tazobactam in tertiary care hospital M Al Nuhait, LC Abu Esba, K Al Harbi, M Al Meshary, RT Bustami International Journal of Pediatrics 2018, 1-7, 2018 | 13 | 2018 |
| Fixed dose combinations: a formulary decision guide LCA Esba, C Yousef, S Ismail, M Halim, H Almodaimegh, ... Health Policy and Technology 10 (2), 100500, 2021 | 9 | 2021 |
| Linezolid vs vancomycin in induced thrombocytopenia LCAE Dimah Al-Harbi, Abdulrahman Al Turaiki, Ayshah Alshngeetee,Haya Aldabas ... Infectious Diseases and Therapy 11 (3), 2022 | 6 | 2022 |
| Pharmacy and therapeutics committee preparedness plan for COVID-19 LC Abu Esba, HA Al-Abdulkarim, A Alrushidan, M Al Harbi Global Journal on Quality and Safety in Healthcare 3 (2), 55-64, 2020 | 6 | 2020 |
| An annual formulary review strategy implemented by a Saudi health system LCA Esba Pharmacy and Therapeutics 41 (8), 513, 2016 | 6 | 2016 |
| An Institutional Guide for Formulary Decisions of Biosimilars CY Sherin Ismail, Laila Abu Esba, Mansoor Khan, Hana Al-Abdulkarim, Hind ... Hospital Pharmacy, 2022 | 5* | 2022 |
| Humanistic and economic burden of atopic dermatitis for adults and adolescents in the Middle East and Africa region B Elezbawy, AN Fasseeh, E Fouly, M Tannira, H Dalle, S Aderian, ... Dermatology and Therapy 13 (1), 131-146, 2023 | 4 | 2023 |
| Predicting health care providers' acceptance of a personal health record secure messaging feature CC Yousef, TM Salgado, A Farooq, K Burnett, LE McClelland, LCA Esba, ... Applied Clinical Informatics 13 (01), 148-160, 2022 | 4 | 2022 |
| P&T committee drug prioritization criteria: a tool developed by a Saudi health care system LCA Esba, H Almodaimegh, A Alhammad, M Ferwana, C Yousef, S Ismail Pharmacy and Therapeutics 43 (5), 293, 2018 | 4 | 2018 |
| The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia Journal of Medical Economics, 2022 | 2 | 2022 |
| Can’t Find the Antidote: A Root Cause Analysis LC Abu Esba, G Mardawi, M Al Deeb Frontiers in Pharmacology, 2022 | 2 | 2022 |
| Saudi Consensus for GLP-1 RAs Switching Guidance: Consensus Report ERI Saud Alsifri, Hussein Elbadawi, Fahad Alsabaan, Abdulraouf Almahfouz ... International Journal of Clinical Medicine 13 (1), 2022 | 2 | 2022 |
| Complementing ADR data by utilizing electronic health records: experience form a tertiary care hospital in Saudi Arabia LCA Esba J Pharmacovigil 7 (1), 2019 | 2 | 2019 |
| Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users FA Nouf Al-Fadel, Abdulaali Almutairi, Tahrir Aldhirgham, Laila Abuesba ... Pharmacoepidemiology and Drug Safety, 2023 | 1* | 2023 |
